Baxter (NYSE: BAX) reported Q1 EPS of $0.59, $0.10 better than the analyst estimate of $0.49. Revenue for the quarter came in at $3.65 billion versus the consensus estimate of $3.6 billion.

GUIDANCE:

Baxter sees FY2023 EPS of $2.85-$3.00, versus the consensus of $2.86.

Baxter sees Q2 2023 EPS of $0.59-$0.61, versus the consensus of $0.60.

For earnings history and earnings-related data on Baxter (BAX) click here.